Clinical trialNCT07057791RecruitingPhase 2Interventional

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

SponsorPrECOG, LLC.Enrollment60Extensive Stage Lung Small Cell Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Taofeek Owonikoko, MD, PhD
University of Maryland, Baltimore
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Miami
Miami, Florida, United States
Chukwuemeka Ikpeazu, MD
Recruiting
University of Maryland
Baltimore, Maryland, United States
Katherine Scilla, MD
Recruiting
Morristown Medical Center
Morristown, New Jersey, United States
Karim Saab, MD
Recruiting
Rutgers Cancer Institute
New Brunswick, New Jersey, United States
Missak Haigentz, MD
Recruiting
Montefiore Medical Center- Montefiore Medical Park
The Bronx, New York, United States
Balazs Halmos, MD
Recruiting
Ohio State Univerity
Columbus, Ohio, United States
Asrar Alahmadi, MD
Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Parth Desai, MD
Recruiting
Guthrie
Sayre, Pennsylvania, United States
Joyson Poulose, MD
Recruiting
Universtiy of Virginia
Charlottesville, Virginia, United States
Ryan Gentzler, MD, MS
Recruiting
Aspirus Cancer Center Wausau
Wausau, Wisconsin, United States
Thomas Oliver, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Mar 2026
Primary completion: 31 Dec 2027
Completion: 31 Jan 2030
Last update posted: 29 Jun 2026
Registered enrollment: 60
Registry id: NCT07057791

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.